Actinium Pharmaceuticals Announced Data Was Presented At Society Of Immunotherapy Of Cancer Annual Meeting, For Actimab-A, Targeted Radiotherapeutic Comprised Of The CD33 Targeting Antibody Lintuzumab And The Actinium-225 Alpha-particle Emitting Payload
Benzinga Newsdesk - Nov 6, 2023, 8:01AM